Femtech

Femtech, a child sector within Superscout's Healthcare category, encompasses the technology products and services that address women's health across the lifecycle, including fertility and reproductive health, pregnancy and postpartum care, menopause management, pelvic health, hormonal health, and conditions like endometriosis and PCOS that disproportionately affect women. With 7 funders actively investing in femtech startups tracked in Superscout's database, the sector has grown from a niche category to a recognized healthcare vertical, with the global femtech market projected to exceed $75 billion by 2030.

The femtech investment thesis is driven by the massive gap between women's healthcare needs and the available solutions. Women make 80% of healthcare decisions, spend more on healthcare than men, and yet women's health conditions have historically been underfunded in both research and commercial product development. This gap creates a large addressable market with relatively little competition: companies building evidence-based solutions for fertility, menopause, maternal health, and chronic conditions affecting women are addressing underserved patient populations with high willingness to pay.

For femtech founders, the 2025-2026 funding environment rewards companies with clinical evidence supporting their products, clear paths to reimbursement through employer benefits or insurance, and the ability to build long-term patient relationships that span multiple life stages.